• PIPAC is typically placed as an adjunct for systemic chemotherapy in between the cycles of chemotherapy. Hence systemic chemotherapy treats primary tumor and distant disease whereas PIPAC treats the peritoneal disease.
• Aerosolization and pressurization drives chemotherapy deeper into the tumor tissues which results in better distribution and tumor killing.
• Due to Minimal-invasive approach repetitive PIPAC application is possible with low morbidity and response can be assessed every time.
• Reduces the incidence of bowel obstructions and ascites.
• Improved survival and better quality of life